ClinicalTrials.gov record
Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)
ClinicalTrials.gov ID: NCT00054717
Public ClinicalTrials.gov record NCT00054717. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low-dose Ritonavir (TPV/RTV) Verses Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Demonstrate the safety and efficacy of Tipranavir/Ritonavir versus an active treatment regimen in highly treatment experienced Human Immunodeficiency virus 1(HIV-1) infected patients.
Study identification
- NCT ID
- NCT00054717
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 630 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2002
- Primary completion
- Aug 31, 2008
- Completion
- Not listed
- Last update posted
- Jul 1, 2014
Started 2003
United States locations
- U.S. sites
- 96
- U.S. states
- 33
- U.S. cities
- 70
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1182.12.62 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 1182.12.108 El Rio SIA | Tucson | Arizona | — | — |
| 1182.12.9 Boehringer Ingelheim Investigational Site | Berkeley | California | — | — |
| 1182.12.23 Boehringer Ingelheim Investigational Site | Beverly Hills | California | — | — |
| 1182.12.12 Boehringer Ingelheim Investigational Site | Fountain Valley | California | — | — |
| 1182.12.76 Boehringer Ingelheim Investigational Site | Long Beach | California | — | — |
| 1182.12.1 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1182.12.59 David Geffen School of Medicine at UCLA | Los Angeles | California | — | — |
| 1182.12.82 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1182.12.97 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1182.12.69 UC Davis Medical Center | Sacramento | California | — | — |
| 1182.12.89 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 1182.12.99 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 1182.12.25 Boehringer Ingelheim Investigational Site | San Francisco | California | — | — |
| 1182.12.5 Boehringer Ingelheim Investigational Site | San Francisco | California | — | — |
| 1182.12.53 Boehringer Ingelheim Investigational Site | San Francisco | California | — | — |
| 1182.12.98 University of Colorado Health Sciences Center | Denver | Colorado | — | — |
| 1182.12.7 Boehringer Ingelheim Investigational Site | Norwalk | Connecticut | — | — |
| 1182.12.103 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 1182.12.52 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 1182.12.70 | Washington D.C. | District of Columbia | — | — |
| 1182.12.79 Boehringer Ingelheim Investigational Site | Fort Lauderdale | Florida | — | — |
| 1182.12.77 Boehringer Ingelheim Investigational Site | Fort Myers | Florida | — | — |
| 1182.12.45 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1182.12.75 CARES Resource | Miami | Florida | — | — |
| 1182.12.85 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1182.12.93 Boehringer Ingelheim Investigational Site | Miami Beach | Florida | — | — |
| 1182.12.17 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 1182.12.90 Boehringer Ingelheim Investigational Site | Sarasota | Florida | — | — |
| 1182.12.63 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 1182.12.78 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 1182.12.94 Infectious Disease Research Institute | Tampa | Florida | — | — |
| 1182.12.67 Boehringer Ingelheim Investigational Site | Vero Beach | Florida | — | — |
| 1182.12.123 Infectious Disease Clinics of Emory | Atlanta | Georgia | — | — |
| 1182.12.88 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 1182.12.72 Boehringer Ingelheim Investigational Site | Decatur | Georgia | — | — |
| 1182.12.47 Boehringer Ingelheim Investigational Site | Macon | Georgia | — | — |
| 1182.12.8 Family Practice Medical Center | Boise | Idaho | — | — |
| 1182.12.105 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1182.12.3 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1182.12.49 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1182.12.32 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 1182.12.48 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 1182.12.33 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 1182.12.44 Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| 1182.12.95 Boehringer Ingelheim Investigational Site | New Orleans | Louisiana | — | — |
| 1182.12.81 Boehringer Ingelheim Investigational Site | Portland | Maine | — | — |
| 1182.12.30 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1182.12.6 Boehringer Ingelheim Investigational Site | Bethesda | Maryland | — | — |
| 1182.12.100 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 1182.12.101 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 1182.12.41 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 1182.12.61 Boehringer Ingelheim Investigational Site | Springfield | Massachusetts | — | — |
| 1182.12.13 University of Michigan Health System | Ann Arbor | Michigan | — | — |
| 1182.12.54 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 1182.12.56 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 1182.12.120 Department of Medicine, HIV/AIDS Program | Minneapolis | Minnesota | — | — |
| 1182.12.14 Dybedal Center for Clinical Research | Kansas City | Missouri | — | — |
| 1182.12.87 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 1182.12.11 Wellness Center | Las Vegas | Nevada | — | — |
| 1182.12.4 Boehringer Ingelheim Investigational Site | Camden | New Jersey | — | — |
| 1182.12.21 Boehringer Ingelheim Investigational Site | East Orange | New Jersey | — | — |
| 1182.12.40 Boehringer Ingelheim Investigational Site | Santa Fe | New Mexico | — | — |
| 1182.12.68 Boehringer Ingelheim Investigational Site | Albany | New York | — | — |
| 1182.12.34 Boehringer Ingelheim Investigational Site | Mount Vernon | New York | — | — |
| 1182.12.119 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.12.22 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.12.36 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.12.58 Beth Israel Medical Center | New York | New York | — | — |
| 1182.12.96 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.12.107 Boehringer Ingelheim Investigational Site | Rochester | New York | — | — |
| 1182.12.83 Boehringer Ingelheim Investigational Site | Stony Brook | New York | — | — |
| 1182.12.43 Boehringer Ingelheim Investigational Site | Valhalla | New York | — | — |
| 1182.12.42 Boehringer Ingelheim Investigational Site | Durham | North Carolina | — | — |
| 1182.12.46 Boehringer Ingelheim Investigational Site | Huntersville | North Carolina | — | — |
| 1182.12.109 Boehringer Ingelheim Investigational Site | Akron | Ohio | — | — |
| 1182.12.24 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 1182.12.35 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 1182.12.65 Ohio State University Medical Center | Columbus | Ohio | — | — |
| 1182.12.80 Infectious Disease Institute Clinical Trials Unit | Oklahoma City | Oklahoma | — | — |
| 1182.12.114 Pinnacle Health | Harrisburg | Pennsylvania | — | — |
| 1182.12.28 University of Pennsylvania | Philadelphia | Pennsylvania | — | — |
| 1182.12.50 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1182.12.86 The Miriam Hospital | Providence | Rhode Island | — | — |
| 1182.12.10 Boehringer Ingelheim Investigational Site | Columbia | South Carolina | — | — |
| 1182.12.116 Greenville Hospital System | Greenville | South Carolina | — | — |
| 1182.12.2 Boehringer Ingelheim Investigational Site | Memphis | Tennessee | — | — |
| 1182.12.106 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 1182.12.55 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 1182.12.31 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1182.12.73 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1182.12.26 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 1182.12.91 Boehringer Ingelheim Investigational Site | Annandale | Virginia | — | — |
| 1182.12.122 VCU Health Systems | Richmond | Virginia | — | — |
| 1182.12.15 Boehringer Ingelheim Investigational Site | Seattle | Washington | — | — |
| 1182.12.29 Boehringer Ingelheim Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00054717, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00054717 live on ClinicalTrials.gov.